Evolve HealthCare Partners (“EHP”) is a mid-market private equity firm founded by former international C-level healthcare executives and investors that aims to partner with European healthcare companies with growth and/or strategic repositioning ambitions, both organically or via M&A. 

EHP’s approach to value creation is operationally focused and hands-on, thus well-placed to apply differentiated investment strategies focused on improving the growth profile of companies in the healthcare space and being able to generate above average returns to investors in a sector that continues to progress and inspire. 



Evolve HealthCare Partners partners with Cera Care to accelerate continued growth 

Barcelona, Spain – Evolve HealthCare Partners, (“Evolve”), the European mid-market specialist investor in healthcare, together with the existing institutional shareholders, have led a capital injection in Cera Care (“Cera” or the “Company”) to support and accelerate its continuous growth. 

Evolve has co-invested alongside Schroder Adveq. 


Healthcare Private Equity:  Investing in Post-COVID world

The global Covid-19 crisis will lead to unprecedented change.  

Certain healthcare sectors will be re-defined as strategic infrastructure and new trends will emerge that will persist beyond the crisis.  

We examine the five key post-Covid-19 trends and the likely investment opportunities that will arise.


Europe creating more Healthcare specific funds

Novel approaches to value creation in healthcare private equity


Evolve Healthcare Partners featured in the Laing &  Buisson Private Equity in Healthcare Market Report 4ed

In addition to traditional levers, a more pragmatic and hands on approach is required to unlock the full potential of healthcare private equity investments

© 2019 

All Rights Reserved